News
FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is ...
FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO) with major operations ...
Regeneron is the facility’s third major ... invest $2 billion and bring 725 jobs to a new manufacturing site in Holly Springs, a Wake County town of 46,000 southwest of Raleigh.
Regeneron Pharmaceuticals Inc. agreed to pay Fujifilm Diosynth Biotechnologies more than $3 billion over the next decade to ...
(Reuters) -Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug ...
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...
Regeneron employee works on a pharmaceutical drug. Photo courtesy of Regeneron Pharmaceuticals HOLLY SPRINGS, N.C. – FujiFilm Diosynth Biotechnologies today announced ...
Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...
Ahead of its scheduled opening later this year, the massive Fujifilm Diosynth Biotechnologies manufacturing plant in Holly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results